Table 1.

Subject Characteristics According to T Status

Normal TTNormal TTP ValueLow TTP ValueLow TTP Value
Normal cFTLow cFTNormal cFTLow cFT
N, % 2641 (79.2%)277 (8.3%)96 (2.9%)320 (9.6%)
General
    Age, y58.9 (10.7)68.4 (9.3)<.00154.7 (9.2)<.00163.4 (10.8)<.001
    Current smoking, %21.719.3.35816.8.26318.6.211
    Alcohol (≥5 days/week), %23.022.2.76024.0.83420.8.373
    Fair or poor general health, %30.350.6<.00128.4.69644.6<.001
    ≥1 comorbidity, %60.379.9<.00163.5.52080.4<.001
Hormonal measurements
    Total T, nmol/liter18.4 (5.5)14.2 (3.7)<.0019.6 (0.7)<.0017.8 (2.5)<.001
    Calculated free T, pmol/liter325.7 (74.2)194.3 (22.7)<.001246.8 (19.5)<.001159.8 (55.3)<.001
    Total estradiol, pmol/liter76.7 (23.6)70.1 (25.7)<.00158.9 (17.6)<.00154.8 (19.6)<.001
    Free estradiol, pmol/liter1.3 (0.4)1.0 (0.4)<.0011.2 (0.4).0401.0 (0.4)<.001
    SHBG, nmol/liter43.2 (17.2)58.1 (21.9)<.00118.9 (4.2)<.00131.6 (15.0)<.001
    LH, U/liter5.9 (3.0)8.8 (6.8)<.0014.8 (2.2).0066.9 (6.8)<.001
    TSH, U/liter1.7 (1.2)1.6 (1.2).6801.7 (1.8).5231.8 (1.7).050
    Free T4, ng/dL1.26 (0.22)1.27 (0.23).4031.24 (0.24).5501.23 (0.24).030
    IGF-1, ng/mL134.5 (42.3)116.5 (43.3)<.001152.9 (47.2)<.001128.3 (57.0).015
Sexual function
    Overall sexual function score21.8 (6.8)17.6 (7.2)<.00123.1 (5.4).08718.9 (7.5)<.001
    % men infrequent sexual thoughts25.142.3<.00116.1.05239.7<.001
    % men erectile dysfunction27.051.0<.00118.1.05945.2<.001
    % men infrequent morning erections35.564.1<.00135.9.93451.7<.001
    % men with 3 sexual symptoms9.325.9<.0015.5.22023.5<.001
Physical function
    Time to walk 50 feet, sec13.4 (3.2)25.0 (5.0)<.00113.2 (2.6).58114.4 (3.3)<.001
    SF36 physical function score50.7 (7.7)46.2 (9.6)<.00150.9 (7.9).84547.6 (8.9)<.001
    % men reduced vigorous activity21.941.7<.00119.2.52938.6<.001
    % men impairment in walking 1 km2.57.0<.0013.2.6787.0<.001
    % men impairment in bending5.213.8<.0012.1.19912.0<.001
Psychological function
    Beck depression inventory score6.7 (6.4)8.1 (7.0).0016.0 (5.7).2627.8 (6.7).005
    % men with sadness4.05.4.2383.2.6976.0.083
    % men with loss of energy5.39.5.00507.9.059
    % men with fatigue4.98.7.0094.2.7479.2.002
Biochemical measurements
    Hemoglobin, g/liter150.1 (10.7)146.4 (10.9)<.001148.7 (9.4).243146.2 (13.0)<.001
    hs-CRP, mg/liter0.39 (0.66)0.61 (1.11)<.0010.63 (0.94).0160.77 (1.52)<.001
    Glucose, mmol/liter5.5 (1.2)6.0 (2.0)<.0016.0 (1.6)<.0016.2 (2.0)<.001
    HOMA-IR2.9 (3.4)4.3 (6.1)<.0014.4 (3.3)<.0015.5 (6.7)<.001
Body composition parameters
    Waist circumference, cm97.1 (10.4)99.9 (11.7)<.001105.4 (9.5)<.001106.5 (12.1)<.001
    Weight, kg82.3 (12.9)82.2 (14.7).92492.3 (14.0)<.00190.9 (16.2)<.001
    BMI, kg/m227.2 (3.7)27.7 (3.8).03929.9 (3.9)<.00130.3 (4.4)<.001
    Estimated % body fat27.4 (5.1)28.0 (5.5).04930.7 (4.2)<.00130.3 (5.3)<.001
    Mid-upper arm circumference (cm)31.6 (3.1)31.3 (3.5).10833.8 (3.8)<.00133.6 (3.8)<.001
    Having MetS, %29.344.6<.00163.2<.00162.5<.001
Bone ultrasound measurements
    Speed of sound, m/sec1552 (32)1542 (32)<.0011549 (27).3951543 (30)<.001
    Broadband ultrasound attenuation, dB/MHz80.7 (17.9)74.9 (19.9)<.00181.1 (16.0).85577.0 (18.0).001
    Quantitative ultrasound index98.4 (20.0)91.8 (20.6)<.00197.3 (16.7).60593.3 (19.1)<.001
    Estimated heel bone mineral density, g/cm20.55 (0.13)0.50 (0.13)<.0010.54 (0.11).6230.51 (0.12)<.001
Normal TTNormal TTP ValueLow TTP ValueLow TTP Value
Normal cFTLow cFTNormal cFTLow cFT
N, % 2641 (79.2%)277 (8.3%)96 (2.9%)320 (9.6%)
General
    Age, y58.9 (10.7)68.4 (9.3)<.00154.7 (9.2)<.00163.4 (10.8)<.001
    Current smoking, %21.719.3.35816.8.26318.6.211
    Alcohol (≥5 days/week), %23.022.2.76024.0.83420.8.373
    Fair or poor general health, %30.350.6<.00128.4.69644.6<.001
    ≥1 comorbidity, %60.379.9<.00163.5.52080.4<.001
Hormonal measurements
    Total T, nmol/liter18.4 (5.5)14.2 (3.7)<.0019.6 (0.7)<.0017.8 (2.5)<.001
    Calculated free T, pmol/liter325.7 (74.2)194.3 (22.7)<.001246.8 (19.5)<.001159.8 (55.3)<.001
    Total estradiol, pmol/liter76.7 (23.6)70.1 (25.7)<.00158.9 (17.6)<.00154.8 (19.6)<.001
    Free estradiol, pmol/liter1.3 (0.4)1.0 (0.4)<.0011.2 (0.4).0401.0 (0.4)<.001
    SHBG, nmol/liter43.2 (17.2)58.1 (21.9)<.00118.9 (4.2)<.00131.6 (15.0)<.001
    LH, U/liter5.9 (3.0)8.8 (6.8)<.0014.8 (2.2).0066.9 (6.8)<.001
    TSH, U/liter1.7 (1.2)1.6 (1.2).6801.7 (1.8).5231.8 (1.7).050
    Free T4, ng/dL1.26 (0.22)1.27 (0.23).4031.24 (0.24).5501.23 (0.24).030
    IGF-1, ng/mL134.5 (42.3)116.5 (43.3)<.001152.9 (47.2)<.001128.3 (57.0).015
Sexual function
    Overall sexual function score21.8 (6.8)17.6 (7.2)<.00123.1 (5.4).08718.9 (7.5)<.001
    % men infrequent sexual thoughts25.142.3<.00116.1.05239.7<.001
    % men erectile dysfunction27.051.0<.00118.1.05945.2<.001
    % men infrequent morning erections35.564.1<.00135.9.93451.7<.001
    % men with 3 sexual symptoms9.325.9<.0015.5.22023.5<.001
Physical function
    Time to walk 50 feet, sec13.4 (3.2)25.0 (5.0)<.00113.2 (2.6).58114.4 (3.3)<.001
    SF36 physical function score50.7 (7.7)46.2 (9.6)<.00150.9 (7.9).84547.6 (8.9)<.001
    % men reduced vigorous activity21.941.7<.00119.2.52938.6<.001
    % men impairment in walking 1 km2.57.0<.0013.2.6787.0<.001
    % men impairment in bending5.213.8<.0012.1.19912.0<.001
Psychological function
    Beck depression inventory score6.7 (6.4)8.1 (7.0).0016.0 (5.7).2627.8 (6.7).005
    % men with sadness4.05.4.2383.2.6976.0.083
    % men with loss of energy5.39.5.00507.9.059
    % men with fatigue4.98.7.0094.2.7479.2.002
Biochemical measurements
    Hemoglobin, g/liter150.1 (10.7)146.4 (10.9)<.001148.7 (9.4).243146.2 (13.0)<.001
    hs-CRP, mg/liter0.39 (0.66)0.61 (1.11)<.0010.63 (0.94).0160.77 (1.52)<.001
    Glucose, mmol/liter5.5 (1.2)6.0 (2.0)<.0016.0 (1.6)<.0016.2 (2.0)<.001
    HOMA-IR2.9 (3.4)4.3 (6.1)<.0014.4 (3.3)<.0015.5 (6.7)<.001
Body composition parameters
    Waist circumference, cm97.1 (10.4)99.9 (11.7)<.001105.4 (9.5)<.001106.5 (12.1)<.001
    Weight, kg82.3 (12.9)82.2 (14.7).92492.3 (14.0)<.00190.9 (16.2)<.001
    BMI, kg/m227.2 (3.7)27.7 (3.8).03929.9 (3.9)<.00130.3 (4.4)<.001
    Estimated % body fat27.4 (5.1)28.0 (5.5).04930.7 (4.2)<.00130.3 (5.3)<.001
    Mid-upper arm circumference (cm)31.6 (3.1)31.3 (3.5).10833.8 (3.8)<.00133.6 (3.8)<.001
    Having MetS, %29.344.6<.00163.2<.00162.5<.001
Bone ultrasound measurements
    Speed of sound, m/sec1552 (32)1542 (32)<.0011549 (27).3951543 (30)<.001
    Broadband ultrasound attenuation, dB/MHz80.7 (17.9)74.9 (19.9)<.00181.1 (16.0).85577.0 (18.0).001
    Quantitative ultrasound index98.4 (20.0)91.8 (20.6)<.00197.3 (16.7).60593.3 (19.1)<.001
    Estimated heel bone mineral density, g/cm20.55 (0.13)0.50 (0.13)<.0010.54 (0.11).6230.51 (0.12)<.001

Continuous variables are expressed as mean (standard deviation), categorical variables as percentages. P value for unadjusted linear (continuous variables) and logistic (categorical variables) regression, with normal TT/normal cFT as the referent group.

TSH, thyroid stimulating hormone; free T4, free thyroxin; HOMA-IR: homeostasis model assessment of insulin resistance.

Table 1.

Subject Characteristics According to T Status

Normal TTNormal TTP ValueLow TTP ValueLow TTP Value
Normal cFTLow cFTNormal cFTLow cFT
N, % 2641 (79.2%)277 (8.3%)96 (2.9%)320 (9.6%)
General
    Age, y58.9 (10.7)68.4 (9.3)<.00154.7 (9.2)<.00163.4 (10.8)<.001
    Current smoking, %21.719.3.35816.8.26318.6.211
    Alcohol (≥5 days/week), %23.022.2.76024.0.83420.8.373
    Fair or poor general health, %30.350.6<.00128.4.69644.6<.001
    ≥1 comorbidity, %60.379.9<.00163.5.52080.4<.001
Hormonal measurements
    Total T, nmol/liter18.4 (5.5)14.2 (3.7)<.0019.6 (0.7)<.0017.8 (2.5)<.001
    Calculated free T, pmol/liter325.7 (74.2)194.3 (22.7)<.001246.8 (19.5)<.001159.8 (55.3)<.001
    Total estradiol, pmol/liter76.7 (23.6)70.1 (25.7)<.00158.9 (17.6)<.00154.8 (19.6)<.001
    Free estradiol, pmol/liter1.3 (0.4)1.0 (0.4)<.0011.2 (0.4).0401.0 (0.4)<.001
    SHBG, nmol/liter43.2 (17.2)58.1 (21.9)<.00118.9 (4.2)<.00131.6 (15.0)<.001
    LH, U/liter5.9 (3.0)8.8 (6.8)<.0014.8 (2.2).0066.9 (6.8)<.001
    TSH, U/liter1.7 (1.2)1.6 (1.2).6801.7 (1.8).5231.8 (1.7).050
    Free T4, ng/dL1.26 (0.22)1.27 (0.23).4031.24 (0.24).5501.23 (0.24).030
    IGF-1, ng/mL134.5 (42.3)116.5 (43.3)<.001152.9 (47.2)<.001128.3 (57.0).015
Sexual function
    Overall sexual function score21.8 (6.8)17.6 (7.2)<.00123.1 (5.4).08718.9 (7.5)<.001
    % men infrequent sexual thoughts25.142.3<.00116.1.05239.7<.001
    % men erectile dysfunction27.051.0<.00118.1.05945.2<.001
    % men infrequent morning erections35.564.1<.00135.9.93451.7<.001
    % men with 3 sexual symptoms9.325.9<.0015.5.22023.5<.001
Physical function
    Time to walk 50 feet, sec13.4 (3.2)25.0 (5.0)<.00113.2 (2.6).58114.4 (3.3)<.001
    SF36 physical function score50.7 (7.7)46.2 (9.6)<.00150.9 (7.9).84547.6 (8.9)<.001
    % men reduced vigorous activity21.941.7<.00119.2.52938.6<.001
    % men impairment in walking 1 km2.57.0<.0013.2.6787.0<.001
    % men impairment in bending5.213.8<.0012.1.19912.0<.001
Psychological function
    Beck depression inventory score6.7 (6.4)8.1 (7.0).0016.0 (5.7).2627.8 (6.7).005
    % men with sadness4.05.4.2383.2.6976.0.083
    % men with loss of energy5.39.5.00507.9.059
    % men with fatigue4.98.7.0094.2.7479.2.002
Biochemical measurements
    Hemoglobin, g/liter150.1 (10.7)146.4 (10.9)<.001148.7 (9.4).243146.2 (13.0)<.001
    hs-CRP, mg/liter0.39 (0.66)0.61 (1.11)<.0010.63 (0.94).0160.77 (1.52)<.001
    Glucose, mmol/liter5.5 (1.2)6.0 (2.0)<.0016.0 (1.6)<.0016.2 (2.0)<.001
    HOMA-IR2.9 (3.4)4.3 (6.1)<.0014.4 (3.3)<.0015.5 (6.7)<.001
Body composition parameters
    Waist circumference, cm97.1 (10.4)99.9 (11.7)<.001105.4 (9.5)<.001106.5 (12.1)<.001
    Weight, kg82.3 (12.9)82.2 (14.7).92492.3 (14.0)<.00190.9 (16.2)<.001
    BMI, kg/m227.2 (3.7)27.7 (3.8).03929.9 (3.9)<.00130.3 (4.4)<.001
    Estimated % body fat27.4 (5.1)28.0 (5.5).04930.7 (4.2)<.00130.3 (5.3)<.001
    Mid-upper arm circumference (cm)31.6 (3.1)31.3 (3.5).10833.8 (3.8)<.00133.6 (3.8)<.001
    Having MetS, %29.344.6<.00163.2<.00162.5<.001
Bone ultrasound measurements
    Speed of sound, m/sec1552 (32)1542 (32)<.0011549 (27).3951543 (30)<.001
    Broadband ultrasound attenuation, dB/MHz80.7 (17.9)74.9 (19.9)<.00181.1 (16.0).85577.0 (18.0).001
    Quantitative ultrasound index98.4 (20.0)91.8 (20.6)<.00197.3 (16.7).60593.3 (19.1)<.001
    Estimated heel bone mineral density, g/cm20.55 (0.13)0.50 (0.13)<.0010.54 (0.11).6230.51 (0.12)<.001
Normal TTNormal TTP ValueLow TTP ValueLow TTP Value
Normal cFTLow cFTNormal cFTLow cFT
N, % 2641 (79.2%)277 (8.3%)96 (2.9%)320 (9.6%)
General
    Age, y58.9 (10.7)68.4 (9.3)<.00154.7 (9.2)<.00163.4 (10.8)<.001
    Current smoking, %21.719.3.35816.8.26318.6.211
    Alcohol (≥5 days/week), %23.022.2.76024.0.83420.8.373
    Fair or poor general health, %30.350.6<.00128.4.69644.6<.001
    ≥1 comorbidity, %60.379.9<.00163.5.52080.4<.001
Hormonal measurements
    Total T, nmol/liter18.4 (5.5)14.2 (3.7)<.0019.6 (0.7)<.0017.8 (2.5)<.001
    Calculated free T, pmol/liter325.7 (74.2)194.3 (22.7)<.001246.8 (19.5)<.001159.8 (55.3)<.001
    Total estradiol, pmol/liter76.7 (23.6)70.1 (25.7)<.00158.9 (17.6)<.00154.8 (19.6)<.001
    Free estradiol, pmol/liter1.3 (0.4)1.0 (0.4)<.0011.2 (0.4).0401.0 (0.4)<.001
    SHBG, nmol/liter43.2 (17.2)58.1 (21.9)<.00118.9 (4.2)<.00131.6 (15.0)<.001
    LH, U/liter5.9 (3.0)8.8 (6.8)<.0014.8 (2.2).0066.9 (6.8)<.001
    TSH, U/liter1.7 (1.2)1.6 (1.2).6801.7 (1.8).5231.8 (1.7).050
    Free T4, ng/dL1.26 (0.22)1.27 (0.23).4031.24 (0.24).5501.23 (0.24).030
    IGF-1, ng/mL134.5 (42.3)116.5 (43.3)<.001152.9 (47.2)<.001128.3 (57.0).015
Sexual function
    Overall sexual function score21.8 (6.8)17.6 (7.2)<.00123.1 (5.4).08718.9 (7.5)<.001
    % men infrequent sexual thoughts25.142.3<.00116.1.05239.7<.001
    % men erectile dysfunction27.051.0<.00118.1.05945.2<.001
    % men infrequent morning erections35.564.1<.00135.9.93451.7<.001
    % men with 3 sexual symptoms9.325.9<.0015.5.22023.5<.001
Physical function
    Time to walk 50 feet, sec13.4 (3.2)25.0 (5.0)<.00113.2 (2.6).58114.4 (3.3)<.001
    SF36 physical function score50.7 (7.7)46.2 (9.6)<.00150.9 (7.9).84547.6 (8.9)<.001
    % men reduced vigorous activity21.941.7<.00119.2.52938.6<.001
    % men impairment in walking 1 km2.57.0<.0013.2.6787.0<.001
    % men impairment in bending5.213.8<.0012.1.19912.0<.001
Psychological function
    Beck depression inventory score6.7 (6.4)8.1 (7.0).0016.0 (5.7).2627.8 (6.7).005
    % men with sadness4.05.4.2383.2.6976.0.083
    % men with loss of energy5.39.5.00507.9.059
    % men with fatigue4.98.7.0094.2.7479.2.002
Biochemical measurements
    Hemoglobin, g/liter150.1 (10.7)146.4 (10.9)<.001148.7 (9.4).243146.2 (13.0)<.001
    hs-CRP, mg/liter0.39 (0.66)0.61 (1.11)<.0010.63 (0.94).0160.77 (1.52)<.001
    Glucose, mmol/liter5.5 (1.2)6.0 (2.0)<.0016.0 (1.6)<.0016.2 (2.0)<.001
    HOMA-IR2.9 (3.4)4.3 (6.1)<.0014.4 (3.3)<.0015.5 (6.7)<.001
Body composition parameters
    Waist circumference, cm97.1 (10.4)99.9 (11.7)<.001105.4 (9.5)<.001106.5 (12.1)<.001
    Weight, kg82.3 (12.9)82.2 (14.7).92492.3 (14.0)<.00190.9 (16.2)<.001
    BMI, kg/m227.2 (3.7)27.7 (3.8).03929.9 (3.9)<.00130.3 (4.4)<.001
    Estimated % body fat27.4 (5.1)28.0 (5.5).04930.7 (4.2)<.00130.3 (5.3)<.001
    Mid-upper arm circumference (cm)31.6 (3.1)31.3 (3.5).10833.8 (3.8)<.00133.6 (3.8)<.001
    Having MetS, %29.344.6<.00163.2<.00162.5<.001
Bone ultrasound measurements
    Speed of sound, m/sec1552 (32)1542 (32)<.0011549 (27).3951543 (30)<.001
    Broadband ultrasound attenuation, dB/MHz80.7 (17.9)74.9 (19.9)<.00181.1 (16.0).85577.0 (18.0).001
    Quantitative ultrasound index98.4 (20.0)91.8 (20.6)<.00197.3 (16.7).60593.3 (19.1)<.001
    Estimated heel bone mineral density, g/cm20.55 (0.13)0.50 (0.13)<.0010.54 (0.11).6230.51 (0.12)<.001

Continuous variables are expressed as mean (standard deviation), categorical variables as percentages. P value for unadjusted linear (continuous variables) and logistic (categorical variables) regression, with normal TT/normal cFT as the referent group.

TSH, thyroid stimulating hormone; free T4, free thyroxin; HOMA-IR: homeostasis model assessment of insulin resistance.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close